Se connecter

Bibliographies thématiques / 378.1/2/092 b

Sommaire

Articles de revues
Livres
Chapitres de livres
Rapports d'organisations

Littérature scientifique sur le sujet « 378.1/2/092 b »

Auteur : Grafiati

Publié le 25 juillet 2024

Mis à jour le 31 juillet 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « 378.1/2/092 b ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Articles de revues sur le sujet "378.1/2/092 b"

1

Korphaisarn, Krittiya, Kosin Wirasorn, Suebpong Tanasanvimon, et al. "Efficacy and safety of durvalumab plus tremelimumab for unresectable hepatocellular carcinoma in Thailand: A real-world multicenter observational study." Journal of Clinical Oncology 43, no. 4_suppl (2025): 539. https://doi.org/10.1200/jco.2025.43.4_suppl.539.

Texte intégral

Résumé :

539 Background: Durvalumab plus tremelimumab (Durva/Treme) andatezolizumab plus bevacizumab are preferable first-line therapy for unresectable hepatocellular carcinoma (uHCC). This study aimed to evaluate the efficacy and safety of Durva/Treme in real world setting. Methods: Fifty patients with uHCC who enrolled in the expanded access program (EAP) for Durva/Treme as the first-line treatment from 12 centers in Thailand were included. Analysis was assessed for objective response rate (ORR), survival, and adverse events. We also compared data with the HIMALAYA study. Results: Median follow-up ti

Styles APA, Harvard, Vancouver, ISO, etc.

2

Masui, Rino, Yoshiki Yokoyama, Masayoshi Watanabe, and Shiro Seki. "Preparation of Low Melting Temperature Lithium-Based Binary Salts and Their Physicochemical Properties." ECS Meeting Abstracts MA2024-02, no. 57 (2024): 3869. https://doi.org/10.1149/ma2024-02573869mtgabs.

Texte intégral

Résumé :

Achieving carbon neutrality demands the development of high-performance Li-ion secondary batteries (LIB), driven by a pressing need for electric vehicles and renewable energy storage. Molten salt electrolytes offer promise for enhancing safety and performance due to their exceptional thermal stability and high Li+ transport numbers(1). However, the high operating temperature range of molten salts, stemming from high melting temperatures, presents a significant challenge. In this study, we propose Li salts with low melting points achieved through increased entropy and eutectic effects by mixing

Styles APA, Harvard, Vancouver, ISO, etc.

3

Yin, X. Y., R. L. Zhang, H. Y. Zheng, et al. "OP0159 GENETICALLY DETERMINED CAUSAL RELATIONSHIP BETWEEN GOUT AND CARDIOVASCULAR DISEASE." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 105. http://dx.doi.org/10.1136/annrheumdis-2023-eular.4227.

Texte intégral

Résumé :

BackgroundGout is a common inflammatory arthritis caused by monosodium urate deposits around the joints[1]. The risk of cardiovascular events, including death, is substantially higher in people with gout than in those without gout[2]. Although epidemiological studies have reported a positive correlation between circulating urate levels and cardiac metabolic diseases, the causal relationship between gout and cardiovascular diseases(CVD) is still uncertain[3].ObjectivesThis study aimed to explore the causal relationship between gout and CVD from the genetic level. We examined the potential effec

Styles APA, Harvard, Vancouver, ISO, etc.

4

Abdallah, Abdullah I., Nicola J. Commander, Martin J. Woodward, Steve Spencer, C. Anthony Hart, and Craig Winstanley. "Type III Secretion Homologs Are Present in Brucella melitensis , B. ovis , and B. suis biovars 1, 2, and 3." Current Microbiology 46, no. 4 (2003): 241–45. http://dx.doi.org/10.1007/s00284-002-3789-3.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

5

Ghoneim, M. M., and A. Tawfik. "Voltammetric studies and assay of the anti-inflammatory drug ketoprofen in pharmaceutical formulation and human plasma at a mercury electrode." Canadian Journal of Chemistry 81, no. 8 (2003): 889–96. http://dx.doi.org/10.1139/v03-092.

Texte intégral

Résumé :

The electrochemical reduction of the anti-inflammatory drug ketoprofen was studied in a Britton-Robinson (B-R.) buffer series of pH 211 using dc-polarography, cyclic voltammetry, and coulometry techniques. The electrode reaction pathway of the drug at the dropping mercury electrode was proposed and discussed. A new adsorptive cathodic stripping square-wave voltammetric procedure was optimized for the assay of bulk drug in a B-R. buffer of pH 2.0. The peak current was linear with the drug concentration over the ranges 2 × 109 to 2 × 107 M of the bulk drug, using a 60 s accumulation time peri

Styles APA, Harvard, Vancouver, ISO, etc.

6

Gidney, M. A. J., D. R. Bundle, A. Godard та B. W. Griffiths. "Development and characterization of monoclonal antibodies to pregnancy-specific β1-glycoprotein". Canadian Journal of Biochemistry and Cell Biology 63, № 7 (1985): 737–42. http://dx.doi.org/10.1139/o85-092.

Texte intégral

Résumé :

Six monoclonal antibodies were developed to pregnancy-specific β1-glycoprotein (PSβ1G). Studies of ascitic fluid antibodies by a double-antibody radioimmunoassay (RIA) included an evaluation of titers, dose–response parameters, and mass action properties. Four of the antibodies demonstrated moderate to high titers ranging from 1/40 000 to > 1/120 000, as determined by the specific binding of 125I-labeled PSβ1G. In inhibition studies utilizing a standard containing known quantities of placental PSβ1G, two of the antibodies (AR#11 and B#2) were highly sensitive and only slightly lower in this

Styles APA, Harvard, Vancouver, ISO, etc.

7

Gachango, E., W. Kirk, L. Hanson, A. Rojas, and P. Tumbalam. "First Report of Fusarium torulosum Causing Dry Rot of Seed Potato Tubers in the United States." Plant Disease 95, no. 9 (2011): 1194. http://dx.doi.org/10.1094/pdis-04-11-0291.

Texte intégral

Résumé :

Fusarium dry rot of potato (Solanum tuberosum L.) is a postharvest disease caused by several Fusarium species and is of worldwide importance. Thirteen species of Fusarium have been implicated in fungal dry rots of potatoes worldwide. Among them, eight species have been reported in the northern United States (2). In Michigan potato production, F. sambucinum was the predominant species reported to be affecting seed potato in storage and causing seed piece decay after planting (3). Some previous identifications of F. sambucinum as dry rot may have been F. torulosum since F. torulosum was previous

Styles APA, Harvard, Vancouver, ISO, etc.

8

Yang, Xu, Bowen Chen, Yanyu Wang, et al. "Lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma: A large real-world study from two centers." Journal of Clinical Oncology 40, no. 16_suppl (2022): e16155-e16155. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e16155.

Texte intégral

Résumé :

e16155 Background: Combining lenvatinib (a multikinase inhibitor) with programmed cell death protein-1 (PD-1) inhibitor has been explored in Unresectable hepatocellular carcinoma (uHCC) in phase 1b trials. This study aimed to investigate the real-word efficacy and safety of lenvatinib plus PD-1 inhibitor for large Chinese patients uHCC cohorts. Methods: BCLC stage B or C uHCC patients were included. Data was collected from Oct 2017 to Nov 2021 retrospectively. Patients were treated with lenvatinib and PD-1 inhibitor (pembrolizumab or nivolumab or camrelizumab or sintilimab or toripalimab or ti

Styles APA, Harvard, Vancouver, ISO, etc.

9

Harb, Wael, Mansoor N. Saleh, Kyriakos P. Papadopoulos, et al. "Clinical Trial Results from the Subgroup of Lymphoma/CLL in a Phase 1 Study of ARQ 092, a Novel Pan AKT-Inhibitor." Blood 126, no. 23 (2015): 5116. http://dx.doi.org/10.1182/blood.v126.23.5116.5116.

Texte intégral

Résumé :

Abstract Background: ARQ 092 is an oral allosteric, potent and selective AKT inhibitor with in vitro and in vivo activity in solid and hematological tumors. ARQ 092-101, the first clinical trial of ARQ 092, has enrolled more than 100 subjects with advanced solid tumors or recurrent malignant lymphoma. As reported previously, the dose escalation portion of the study has been completed and two dosing schedules (intermittent and weekly), are recommended for phase 2 studies. The recommended phase 2 dose (RP2D) for the intermittent dosing schedule is 200 mg once daily (QD) (one week on, one week of

Styles APA, Harvard, Vancouver, ISO, etc.

10

Shen, Jian, Chun Chang, Jie Ma, and Qiang Feng. "Potential of Circulating Proangiogenic MicroRNAs for Predicting Major Adverse Cardiac and Cerebrovascular Events in Unprotected Left Main Coronary Artery Disease Patients Who Underwent Coronary Artery Bypass Grafting." Cardiology 146, no. 3 (2021): 400–408. http://dx.doi.org/10.1159/000509275.

Texte intégral

Résumé :

<b><i>Objective:</i></b> This study aimed to explore the association of 14 proangiogenic microRNAs (miRNAs) with major adverse cardiac and cerebrovascular events (MACCE) occurrence in unprotected left main coronary artery disease (ULMCAD) patients who underwent coronary artery bypass grafting (CABG). <b><i>Methods:</i></b> A total of 196 ULMCAD patients who underwent first ever CABG were recruited. The peripheral blood samples were collected prior to CABG, and then plasma samples were separated to detect expressions of 14 proangiogenic miRNAs by

Styles APA, Harvard, Vancouver, ISO, etc.

Plus de sources

Livres sur le sujet "378.1/2/092 b"

1

Jacobus. The Golden Legend: Readings on the Saints, Vol. 1. Princeton University Press, 1995.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Chapitres de livres sur le sujet "378.1/2/092 b"

1

Souza, Leonardo Oliveira de, Marcos Henrique Lins Bentes, Suzete Gomes Faria, and Cheila Maria Lins Bentes. "Capítulo 1 – Adolescência Conceitos e definições." In Adole Saúde. Pontifícia Universidade Católica de São Paulo, 2025. https://doi.org/10.29327/5595655.1-1.

Texte intégral

Résumé :

Você já ouviu alguém mencionar: “Esses adolescentes, ah, melhor esses aborrecentes!!!”, e esquecem que um dia ele ou ela já foi adolescente ou aborrecente, passou pela ponte da transição, da fase infantil para a fase adulta, a ponte é a adolescência que todos nós cruzamos ou iremos cruzar um dia. Ao lermos os Manuais das autoridades de saúde, as políticas públicas, as publicações científicas ou o Estatuto da Criança e o Adolescente (ECA), observamos conceitos e definições um pouco contraditória em relação a idade, quando começa? Quando termina? O que é realmente a adolescência? A delimitação e

Styles APA, Harvard, Vancouver, ISO, etc.

Rapports d'organisations sur le sujet "378.1/2/092 b"

1

พงษ์สามารถ, สุนันท์, วิมลมาศ ลิปิพันธ์ та พนิดา วยัมหสุวรรณ. ศึกษาสารสกัดโพลีแซคคาไรด์จากเปลือกของผลทุเรียนเพื่อใช้ประโยชน์ทางการแพทย์. จุฬาลงกรณ์มหาวิทยาลัย, 2003. https://doi.org/10.58837/chula.res.2003.28.

Texte intégral

Résumé :

แยกสารโพลีแซคคาไรด์ได้ 2 ชนิด จากเปลือกแห้งของผลทุเรียน (Durio zibethinus L.) เตรียมในรูปผงแห้งของ polysaccharide gel (PG) และ polysaccharide fiber (PF) องค์ประกอบธาตุหลักของโพลีแซคคาไรด์ประกอบด้วย Carbon (C) Hydrogen (H) และ Oxygen (O) ในสัดส่วนอะตอมของ C:H:O เท่ากับ 2.9:5.3:3.1 และ 3.5:6.4:3.1 ใน PG และ PF ตามลำดับ PG มีองค์ประกอบของ acidic sugar ได้แก่ galacturonic acid มากกว่าห้าสิบเปอร์เซนต์ ของน้ำหนัก PG และมีน้ำตาล neutral sugar ได้แก่ glucose fructose rhamnose และ arabinose ใน PF มีองค์ประกอบของน้ำตาล glucose เพียงชนิดเดียว ทำการตรวจวิเคราะห์น้ำตาลโดยวิธี colorimetric method TLC และ HP

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!